Silicon Labs Q2 revenue $228M (+18% YoY); non-GAAP EPS $0.71, up 545%

SILICON LABORATORIES INC.

Revenue $228M, up 18% YoY; Industrial & Commercial $135M (+23%), Home & Life $93M (+12%).
Non-GAAP diluted EPS $0.71 (+545% YoY); GAAP diluted loss/share $(0.32), improved 52% YoY.
GAAP gross margin 61.6%; non-GAAP gross margin 61.9%; GAAP operating loss $11M; non-GAAP operating income $27M.
Medical segment set record revenue, up 78% YoY; bookings, design wins accelerated; channel inventory declined.
Forward guidance suspended due to pending Texas Instruments acquisition; merger costs excluded from non-GAAP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.